Island to present at World Antiviral Congress 2022
- Written by PR Newswire
MELBOURNE, Australia, Nov. 15, 2022 /PRNewswire/ -- Australian mid-clinical stage antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA) is pleased to advise that CEO and Managing Director, Dr David Foster will present at the World Antiviral Congress 2022 in San Diego, USA which runs from 28 November – 1 December 2022.
The...
Read more: Island to present at World Antiviral Congress 2022